[go: up one dir, main page]

CL2019002340A1 - Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1. - Google Patents

Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1.

Info

Publication number
CL2019002340A1
CL2019002340A1 CL2019002340A CL2019002340A CL2019002340A1 CL 2019002340 A1 CL2019002340 A1 CL 2019002340A1 CL 2019002340 A CL2019002340 A CL 2019002340A CL 2019002340 A CL2019002340 A CL 2019002340A CL 2019002340 A1 CL2019002340 A1 CL 2019002340A1
Authority
CL
Chile
Prior art keywords
methods
compositions
hair growth
promoting hair
mpc1
Prior art date
Application number
CL2019002340A
Other languages
English (en)
Inventor
William E Lowry
Heather Christofk
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of CL2019002340A1 publication Critical patent/CL2019002340A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EN LA PRESENTE SE PROPORCIONAN MÉTODOS PARA ACELERAR, PROMOVER O RESTAURAR EL CRECIMIENTO DEL CABELLO, QUE COMPRENDEN ADMINISTRARLE A UN SUJETO QUE LO NECESITE UNA CANTIDAD EFICAZ DE UN COMPUESTO DE LA FÓRMULA (I). TAMBIÉN SE PROPORCIONAN COMPOSICIONES QUE COMPRENDEN EL COMPUESTO DE LA FÓRMULA (I).
CL2019002340A 2016-08-26 2019-08-19 Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1. CL2019002340A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662380205P 2016-08-26 2016-08-26
US201762463232P 2017-02-24 2017-02-24

Publications (1)

Publication Number Publication Date
CL2019002340A1 true CL2019002340A1 (es) 2020-01-17

Family

ID=61246282

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019002340A CL2019002340A1 (es) 2016-08-26 2019-08-19 Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1.

Country Status (3)

Country Link
CL (1) CL2019002340A1 (es)
PH (1) PH12019501722A1 (es)
WO (1) WO2018039612A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX389692B (es) 2017-02-24 2025-03-20 Univ California Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc.
CN116120314A (zh) 2017-06-30 2023-05-16 加利福尼亚大学董事会 用于调节毛发生长的组合物和方法
US11724941B2 (en) 2018-02-15 2023-08-15 North Carolina State University Synthesis of micron and nanoscale carbon spheres and structures using hydrothemal carbonization
CN113631555A (zh) * 2019-01-02 2021-11-09 加利福尼亚大学董事会 用于调节毛发生长的组合物和方法
JP7497974B2 (ja) * 2019-12-20 2024-06-11 株式会社 資生堂 Ｍｐｃ１抑制により皮膚幹細胞を活性化する方法および皮膚幹細胞活性化剤
US20240327400A1 (en) * 2020-06-30 2024-10-03 The Regents Of The University Of California Compositions and methods for modulating hair growth

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212A (en) 1847-07-31 Richard m
US162A (en) 1837-04-17 Island
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
WO1999038504A1 (en) 1998-01-29 1999-08-05 Sepracor Inc. Pharmaceutical uses of optically pure (-)-bupropion
EP2847356A4 (en) * 2012-05-10 2015-08-05 Univ Utah Res Found COMPOSITIONS AND METHOD FOR MODULATING MITOCHONDRIAL PYRUVATE CARBON ACTIVITY
EP3052133A2 (en) * 2013-10-03 2016-08-10 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof

Also Published As

Publication number Publication date
PH12019501722A1 (en) 2020-06-15
WO2018039612A1 (en) 2018-03-01

Similar Documents

Publication Publication Date Title
CL2019002340A1 (es) Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1.
DOP2019000266A (es) Inhibidores de pd-1/pd-l1
MX2020011104A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
MX2018005829A (es) Composiciones para tratar el cabello.
CL2018001134A1 (es) Composiciones y métodos para inhibir la actividad arginasa
MX2016002077A (es) Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos.
CL2016002516A1 (es) “compuestos derivados de espirociclo sustituidos, inhibidores atx; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer, inflamaciones, dolor neuropático, enfermedades fibróticas, trombosis, entre otros”. pct
CR20150376A (es) Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
GT201700167A (es) Terapias de combinación para el tratamiento de cánceres.
EA201790398A1 (ru) Способы лечения заболевания печени
MX391858B (es) Compuestos terapeuticamente activos y sus metodos de uso
MX2016009898A (es) Tratamientos para acne resistente.
CR20160308A (es) Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
MX2017004600A (es) Compuestos de aminopurina sustituida, composiciones del mismo, y metodos de tratamiento con los mismos.
MX2018006674A (es) Tratamiento de cancer usando 2-desoxi-2-fluoro-l-fucosa en combinacion con un inhibidor del punto de control.
BR112016006048A8 (pt) composições antimicrobianas
CR20170425A (es) Nuevas proteínas específicas para pioverdina y pioquelina
DOP2017000146A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
MX389692B (es) Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
BR112017008481A2 (pt) composto antimicótico
MX2017001352A (es) Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2).
BR112017013498A2 (pt) composições de inibidor de nitrificação e métodos para a preparação das mesmas
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2